Search research articles
Contact Us
Filters
Showing results (281-290 of 323) with videos related to
Page
of 33
Sort By:
Blood
|
June 16, 2021
The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance
Guang Yang, Jinhua Wang, Li Tan, et al.
Blood Cancer Journal
|
July 8, 2026
WNK2 oncogenicity revealed by the discovery and functional characterization of novel gene isoforms in MYD88 mutated Waldenström's Macroglobulinemia
Maria Luisa Guerrera, Xia Liu, Nickolas Tsakmaklis, et al.
British Journal of Haematology
|
April 20, 2025
Development and characterization of the novel MYD88 mutated, 6q deleted BCWM.2 cell line for Waldenström macroglobulinaemia
Shirong Liu, Xia Liu, Choudhury Fabliha Binte Yusuf, et al.
Blood
|
February 24, 2016
Exome sequencing reveals recurrent germ line variants in patients with familial Waldenström macroglobulinemia
Aldo M Roccaro, Antonio Sacco, Jiantao Shi, et al.
ACS Chemical Biology
|
February 22, 2014
Discovery of a potent, covalent BTK inhibitor for B-cell lymphoma
Hong Wu, Wenchao Wang, Feiyang Liu, et al.
Nature Communications
|
February 10, 2025
Single-cell RNA sequencing defines distinct disease subtypes and reveals hypo-responsiveness to interferon in asymptomatic Waldenstrom's Macroglobulinemia
Romanos Sklavenitis-Pistofidis, Yoshinobu Konishi, Daniel Heilpern-Mallory, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2020
Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies
Steven P Treon, Lian Xu, Maria Luisa Guerrera, et al.
Blood
|
July 21, 2021
Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia
Steven P Treon, Kirsten Meid, Zachary R Hunter, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 7, 2011
Multiple myeloma
Kenneth C Anderson, Melissa Alsina, William Bensinger, et al.
Clinical Lymphoma & Myeloma
|
October 13, 2007
Novel agents in the treatment of Waldenström's macroglobulinemia
Steven P Treon, Evdoxia Hatjiharissi, Xavier Leleu, et al.
Page
of 33
Search research articles
Search
Showing results (281-290 of 323) with videos related to
Sort By:
Page
of 33
Blood
|
June 16, 2021
The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance
Guang Yang, Jinhua Wang, Li Tan, et al.
Blood Cancer Journal
|
July 8, 2026
WNK2 oncogenicity revealed by the discovery and functional characterization of novel gene isoforms in MYD88 mutated Waldenström's Macroglobulinemia
Maria Luisa Guerrera, Xia Liu, Nickolas Tsakmaklis, et al.
British Journal of Haematology
|
April 20, 2025
Development and characterization of the novel MYD88 mutated, 6q deleted BCWM.2 cell line for Waldenström macroglobulinaemia
Shirong Liu, Xia Liu, Choudhury Fabliha Binte Yusuf, et al.
Blood
|
February 24, 2016
Exome sequencing reveals recurrent germ line variants in patients with familial Waldenström macroglobulinemia
Aldo M Roccaro, Antonio Sacco, Jiantao Shi, et al.
ACS Chemical Biology
|
February 22, 2014
Discovery of a potent, covalent BTK inhibitor for B-cell lymphoma
Hong Wu, Wenchao Wang, Feiyang Liu, et al.
Nature Communications
|
February 10, 2025
Single-cell RNA sequencing defines distinct disease subtypes and reveals hypo-responsiveness to interferon in asymptomatic Waldenstrom's Macroglobulinemia
Romanos Sklavenitis-Pistofidis, Yoshinobu Konishi, Daniel Heilpern-Mallory, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2020
Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies
Steven P Treon, Lian Xu, Maria Luisa Guerrera, et al.
Blood
|
July 21, 2021
Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia
Steven P Treon, Kirsten Meid, Zachary R Hunter, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 7, 2011
Multiple myeloma
Kenneth C Anderson, Melissa Alsina, William Bensinger, et al.
Clinical Lymphoma & Myeloma
|
October 13, 2007
Novel agents in the treatment of Waldenström's macroglobulinemia
Steven P Treon, Evdoxia Hatjiharissi, Xavier Leleu, et al.
Page
of 33